Ampio: Ampio, Ascendia Partner to Support Clinical Development of OA-201
Ascendia will provide scale-up, GLP supply and method validation, culminating in cGMP manufacturing.
Read full article »
Ampio is a Colorado-based biopharmaceutical company that researches and commercializes novel therapies for the treatment of cancer and inflammatory diseases.
Read more